Holland & Barrett pricing in focus as concerns mount over leverage
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
LevFinLevFin Leveraged Loans

Holland & Barrett pricing in focus as concerns mount over leverage

Protein shake

With the deadline looming on Holland & Barrett’s £825m-equivalent of loans, several investors have raised concerns over both leverage and terms on the deal, in a market otherwise winding down for summer.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article